Alembic
Ticker >

Alembic share price

Alembic Ltd.

NSE: ALEMBICLTD BSE: 506235 SECTOR: Pharmaceuticals & Drugs  77k   279   54

92.53
+1.28 (1.40%)
BSE: 19 Apr 04:01 PM

Price Summary

Today's High

₹ 93

Today's Low

₹ 89.6

52 Week High

₹ 107.5

52 Week Low

₹ 59.87

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2376 Cr.

Enterprise Value

₹ 2374.21 Cr.

No. of Shares

25.68 Cr.

P/E

31.06

P/B

2.79

Face Value

₹ 2

Div. Yield

2.38 %

Book Value (TTM)

₹  33.21

CASH

₹ 1.79 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

70.88 %

EPS (TTM)

₹  2.98

Sales Growth

62.11%

ROE

8.6 %

ROCE

9.24%

Profit Growth

-7.52 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year62.11%
3 Year18.67%
5 Year-0.34%

Profit Growth

1 Year-7.52%
3 Year-5.37%
5 Year13.67%

ROE%

1 Year8.6%
3 Year6.65%
5 Year10.08%

ROCE %

1 Year9.24%
3 Year7.47%
5 Year10.76%

Debt/Equity

0

Price to Cash Flow

68.48

Interest Cover Ratio

545.84358974359

CFO/PAT (5 Yr. Avg.)

0.123688568086794

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 70.88 0
Dec 2023 70.88 0
Sep 2023 70.88 0
Jun 2023 70.88 0
Mar 2023 70.88 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 18.6728362613744% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 545.84358974359.
  • Company has a healthy liquidity position with current ratio of 2.06268486902912.
  • The company has a high promoter holding of 70.88%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 46.0093913025413.

 Limitations

  • The company has shown a poor profit growth of -5.37231547877256% for the Past 3 years.
  • Company has a poor ROE of 6.65230521533962% over the past 3 years.
  • Tax rate is low at 6.73599574566213.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 29.54 36.1 35.65 31.15 37.94
Total Expenditure 19.7 23.32 25.54 21.52 24.8
Operating Profit 9.84 12.78 10.11 9.63 13.14
Other Income 2.37 1.97 2.59 47.86 2.21
Interest 0.03 0.04 0.05 0.05 0.26
Depreciation 1.6 1.61 1.74 1.77 2.57
Exceptional Items 0 -10.61 0 0 0
Profit Before Tax 10.58 2.49 10.91 55.67 12.52
Tax 0.13 -1.8 1.43 4.24 1.23
Profit After Tax 10.45 4.29 9.48 51.43 11.29
Adjusted EPS (Rs) 0.41 0.17 0.37 2 0.44

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 123.81 73.69 72.3 75.97 123.16
Total Expenditure 106.43 70.11 62.21 63.06 85.15
Operating Profit 17.38 3.58 10.09 12.92 38
Other Income 30.16 93.61 10.61 89.09 64.11
Interest 0.22 0.28 0.27 0.23 0.16
Depreciation 2.63 3.23 3.91 4.5 6.36
Exceptional Items 0 0 0 0 -10.61
Profit Before Tax 44.7 93.68 16.52 97.28 85
Tax 3.59 0.13 3.15 11.56 5.73
Net Profit 41.11 93.55 13.36 85.71 79.27
Adjusted EPS (Rs.) 1.6 3.64 0.52 3.34 3.09

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 51.36 51.36 51.36 51.36 51.36
Total Reserves 361.06 431.74 775.46 962.49 777.63
Borrowings 0 0 0 0 0
Other N/C liabilities 8.52 5.87 51.24 63.45 38.12
Current liabilities 48.8 45.3 58.39 66.89 81.04
Total Liabilities 469.74 534.28 936.45 1144.19 948.14
Assets
Net Block 131.11 130.63 133.69 133.5 131.83
Capital WIP 22.26 18.69 37.27 0.19 0.13
Intangible WIP 0 0 0 0 0
Investments 161.82 143.58 565.5 702.38 461.07
Loans & Advances 0.05 0 0.85 4.98 0
Other N/C Assets 55.82 78.79 99.53 162.9 187.96
Current Assets 98.67 162.59 99.62 140.23 167.15
Total Assets 469.74 534.28 936.45 1144.19 948.14
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 44.7 93.68 16.52 97.28 85
Adjustment -20.5 -85.77 1.54 -79.16 -53.46
Changes in Assets & Liabilities 1.97 -0.94 -17.22 -31.35 9.59
Tax Paid -4.64 -1.49 -1.95 -8.64 -6.43
Operating Cash Flow 21.52 5.48 -1.12 -21.87 34.7
Investing Cash Flow 71.66 56.79 -35.15 22.66 11.29
Financing Cash Flow -92.01 -6.4 -15.27 -5.66 -46.08
Net Cash Flow 1.17 55.87 -51.53 -4.86 -0.09

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 70.88 70.88 70.88 70.88 70.88
chirayu ramanbhai amin 3.24 3.24 3.24 3.24 3.24
inaaya shaunak amin 0.02 0.02 0.02 0.02 0.02
malika chirayu amin 2.99 2.99 2.99 2.99 2.99
naintara shaunak amin 0.02 0.02 0.02 0.02 0.02
nirayu limited 63.06 63.06 63.06 63.06 63.06
pranav chirayu amin 0.75 0.75 0.75 0.75 0.75
ranvir pranav amin 0.02 0.02 0.02 0.02 0.02
samira pranav amin 0.02 0.02 0.02 0.02 0.02
shaunak chirayu amin 0.75 0.75 0.75 0.75 0.75
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 29.12 29.12 29.12 29.12 29.12
investor education and pr... 1.14 1.14 1.18 - 1.20
llp 0.03 0.03 0.03 0.03 0.03
investor education and pr... - - - 1.20 -
sbi small cap fund 3.89 3.89 3.36 - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Alembic informs about loss of share certificate 16 Apr 2024, 12:14PM Alembic informs about details of loss of certificate6 Apr 2024, 3:32PM Alembic informs about loss of share certificate1 Apr 2024, 5:02PM Alembic informs about loss of share certificate27 Feb 2024, 2:28PM Alembic informs about loss of share certificate 24 Feb 2024, 11:07AM Alembic informs about loss of share certificate22 Feb 2024, 2:04PM Alembic submits unaudited financial results14 Feb 2024, 5:19PM Alembic - Quaterly Results14 Feb 2024, 4:54PM Alembic - Quaterly Results14 Feb 2024, 4:54PM Alembic informs about loss of share certificate16 Jan 2024, 4:48PM Alembic informs about loss of share certificate9 Jan 2024, 3:53PM Alembic informs about details of loss of certificate4 Dec 2023, 4:32PM Alembic informs about loss of share certificates17 Nov 2023, 5:07PM Alembic informs about loss of share certificates16 Oct 2023, 4:26PM Alembic informs about appointment of independent director11 Aug 2023, 10:10AM Alembic informs about voting results and scrutinizers' report11 Aug 2023, 10:09AM Alembic informs about board decision10 Aug 2023, 5:06PM Alembic - Quaterly Results10 Aug 2023, 4:07PM Alembic - Quaterly Results10 Aug 2023, 4:07PM Alembic informs about loss of share certificates31 Jul 2023, 2:21PM Alembic informs about loss of share certificates24 Jul 2023, 12:20PM Alembic informs about loss of share certificate 20 Jul 2023, 2:09PM Alembic informs about details of loss of certificate 14 Jul 2023, 12:50PM Alembic informs about newspaper publication 13 Jul 2023, 2:11PM Alembic informs about loss of share certificate 26 Jun 2023, 10:34AM ALEMBIC informs about loss of share certificate23 Jun 2023, 4:33PM Alembic informs about loss of share certificate23 Jun 2023, 2:01PM Alembic informs about newspaper publication20 Jun 2023, 1:08PM Alembic informs about loss of share certificate14 Jun 2023, 1:51PM Alembic informs about issue of duplicate share certificate8 Jun 2023, 3:12PM Alembic informs about loss of share certificates31 May 2023, 3:57PM Alembic informs about newspaper publication24 May 2023, 4:24PM Alembic - Quaterly Results12 May 2023, 5:31PM Alembic - Quaterly Results12 May 2023, 5:31PM Alembic informs about loss of share certificate11 May 2023, 2:18PM Alembic informs about loss of share certificate 5 Apr 2023, 12:31PM Alembic informs about loss of share certificate30 Mar 2023, 12:28PM Alembic informs about loss of share certificate20 Mar 2023, 2:25PM Alembic informs about loss of share certificate 13 Mar 2023, 12:43PM Alembic informs about loss of share certificate3 Mar 2023, 4:34PM Alembic informs about loss of share certificate2 Mar 2023, 2:51PM Alembic informs about loss of share certificate22 Feb 2023, 4:54PM Alembic informs about details of loss of certificate21 Feb 2023, 3:26PM Alembic informs about loss of share certificate20 Feb 2023, 12:37PM Alembic informs about issuance of duplicate share certificate15 Feb 2023, 5:22PM Alembic - Quaterly Results9 Feb 2023, 5:07PM Alembic - Quaterly Results9 Feb 2023, 5:07PM Alembic - Quaterly Results9 Feb 2023, 5:07PM Alembic informs about loss of share certificate23 Dec 2022, 2:13PM Alembic informs about loss of share certificate 2 Dec 2022, 9:31AM

Alembic Stock Price Analysis and Quick Research Report. Is Alembic an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Alembic and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Alembic cash from the operating activity was Rs 34.6964 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Alembic has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Alembic , the EPS growth was -7.51647693229479 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Alembic has OPM of 30.8587533371875 % which is a good sign for profitability.
     
  • ROE: Alembic have a poor ROE of 8.60307139447804 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Alembic is Rs 92.7. One can use valuation calculators of ticker to know if Alembic share price is undervalued or overvalued.
Last Updated on:
Brief about Alembic

Alembic Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Alembic Ltd. is one of the leading pharmaceutical companies in India. With a rich history spanning over a century, the company has established itself as a key player in the healthcare industry. Founded in 1907, Alembic has consistently focused on innovation, research, and development to bring high-quality and affordable medicines to people across the globe.

Alembic Ltd. - Share Price

The share price of Alembic Ltd. reflects the market valuation of the company's stock. As a long-term investor, it is essential to analyze the share price trends over a period of time, taking into account factors such as market conditions, company performance, and industry outlook. Our website provides a detailed stock analysis page, where you can track Alembic Ltd.'s share price along with various technical indicators.

Alembic Ltd. - Balance Sheet

Analyzing a company's balance sheet is crucial for understanding its financial health. Alembic Ltd.'s balance sheet showcases its assets, liabilities, and shareholders' equity. By studying this financial statement, investors can gauge the company's liquidity, solvency, and ability to generate profits. Our website offers pre-built screening tools that enable you to perform a comprehensive analysis of Alembic Ltd.'s balance sheet.

Alembic Ltd. - Annual Report

The annual report of Alembic Ltd. provides valuable insights into the company's performance, strategy, and future prospects. It is a comprehensive document that includes financial statements, management discussion and analysis, and other relevant information. As a long-term investor, reviewing the annual report can help you make informed decisions. You can easily access and download Alembic Ltd.'s annual reports from our website.

Alembic Ltd. - Dividend

Dividends are an important aspect of a company's financial strength and shareholder returns. Alembic Ltd. has a consistent track record of rewarding its shareholders through regular dividend payments. By analyzing the dividend history, investors can assess the company's stability and commitment to sharing profits with its shareholders. Our website provides dividend-related information and tools to help you evaluate Alembic Ltd.'s dividend history.

Alembic Ltd. - Quarterly Result

Tracking a company's quarterly results is crucial for understanding its performance and growth trajectory. Alembic Ltd.'s quarterly results provide insights into its revenue, expenses, and profitability on a quarterly basis. By analyzing these results, investors can monitor the company's operational efficiency and financial stability. Our website offers pre-built screening tools that allow you to easily access and analyze Alembic Ltd.'s quarterly results.

Alembic Ltd. - Stock Price

The stock price of Alembic Ltd. is determined by market forces and reflects the perceived value of the company. Analyzing the stock price trends can provide valuable insights into market sentiment and investor expectations. Our website provides a stock analysis page with detailed information on Alembic Ltd.'s stock price, technical indicators, and performance relative to its peers.

Alembic Ltd. - Price Chart

Price charts are powerful tools that help investors visualize the historical movement of a stock's price. Alembic Ltd.'s price chart captures the fluctuations in its stock price over a specific period. By analyzing the price chart, investors can identify patterns, trends, and support/resistance levels. Our website offers pre-built screening tools that include price charts, allowing you to analyze and interpret Alembic Ltd.'s price movements.

Alembic Ltd. - News

Staying updated with the latest news and developments related to Alembic Ltd. is essential for making informed investment decisions. Our website provides a dedicated news section where you can find the latest news articles, press releases, and market updates related to Alembic Ltd. With access to reliable news sources, investors can stay ahead of market trends and gain a deeper understanding of the company's performance.

Alembic Ltd. - Concall Transcripts

Concall transcripts provide valuable insights into the discussions, decisions, and future plans of a company's management. By analyzing Alembic Ltd.'s concall transcripts, investors can gain a deeper understanding of the company's strategy, outlook, and risk factors. Our website provides downloadable concall transcripts, allowing you to stay informed about Alembic Ltd.'s management discussions.

Alembic Ltd. - Investor Presentations

Investor presentations are an important source of information for understanding a company's business model, growth strategy, and financial performance. Alembic Ltd.'s investor presentations provide a comprehensive overview of the company, including its operations, financials, and future prospects. Our website offers downloadable investor presentations, enabling investors to access and analyze Alembic Ltd.'s key investment highlights.

Alembic Ltd. - Promoters

Promoters play a crucial role in the success and growth of a company. Alembic Ltd. has a strong promoter group that has been instrumental in the company's journey. Our website provides detailed information about Alembic Ltd.'s promoters, their background, and their contributions to the company's success. Understanding the promoters' track record and vision can provide valuable insights for long-term investors.

Alembic Ltd. - Shareholders

Analyzing a company's shareholder base can provide insights into its ownership structure and investor sentiment. Alembic Ltd. has a diverse group of shareholders, including retail and institutional investors. Our website offers information about Alembic Ltd.'s major shareholders and their holdings. Understanding the shareholder composition can help investors gauge market confidence and assess the level of institutional support for the company.

At our website, we provide premium features that offer advanced tools for fair value calculation, including DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis. These tools enable long-term investors to evaluate Alembic Ltd.'s intrinsic value, assess its financial performance, and make informed investment decisions.

In addition, we offer a wide range of downloadable resources, including annual reports, concall transcripts, investor presentations, credit ratings, and research reports. These resources provide comprehensive information and analysis to help investors thoroughly evaluate Alembic Ltd. and make informed investment decisions.

Please note that this content is written in a technical tone and is specifically geared towards long-term stock investors looking for stock analysis.

Read More
X